Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Deininger

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Cancer Research|November 3, 2001
Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblastsM W Deininger, S A Vieira, Y Parada, et al.
Leukemia|April 6, 2016
A role for FOXO1 in BCR-ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemiaM Wagle, A M Eiring, M Wongchenko, et al.
Leukemia|February 28, 2015
A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemiaD W Woessner, A M Eiring, B J Bruno, et al.
Leukemia|August 19, 2017
Mechanisms of resistance to the BCR-ABL1 allosteric inhibitor asciminibW Qiang, O Antelope, M S Zabriskie, et al.
British Journal of Cancer|April 22, 2010
Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivoS A Bright, A M McElligott, J W O'Connell, et al.
Leukemia|January 26, 2007
Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinibD W Sherbenou, M J Wong, A Humayun, et al.
Leukemia|July 11, 2008
High-throughput mutational screen of the tyrosine kinome in chronic myelomonocytic leukemiaJ W Tyner, M M Loriaux, H Erickson, et al.
Leukemia|August 3, 2016
Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapyJ S Khorashad, S K Tantravahi, D Yan, et al.
Leukemia|July 24, 2015
β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemiaA M Eiring, J S Khorashad, D J Anderson, et al.
Leukemia|December 10, 2015
Age-related mutations and chronic myelomonocytic leukemiaC C Mason, J S Khorashad, S K Tantravahi, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cancer Research|November 3, 2001
Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblastsM W Deininger, S A Vieira, Y Parada, et al.
Leukemia|April 6, 2016
A role for FOXO1 in BCR-ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemiaM Wagle, A M Eiring, M Wongchenko, et al.
Leukemia|February 28, 2015
A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemiaD W Woessner, A M Eiring, B J Bruno, et al.
Leukemia|August 19, 2017
Mechanisms of resistance to the BCR-ABL1 allosteric inhibitor asciminibW Qiang, O Antelope, M S Zabriskie, et al.
British Journal of Cancer|April 22, 2010
Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivoS A Bright, A M McElligott, J W O'Connell, et al.
Leukemia|January 26, 2007
Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinibD W Sherbenou, M J Wong, A Humayun, et al.
Leukemia|July 11, 2008
High-throughput mutational screen of the tyrosine kinome in chronic myelomonocytic leukemiaJ W Tyner, M M Loriaux, H Erickson, et al.
Leukemia|August 3, 2016
Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapyJ S Khorashad, S K Tantravahi, D Yan, et al.
Leukemia|July 24, 2015
β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemiaA M Eiring, J S Khorashad, D J Anderson, et al.
Leukemia|December 10, 2015
Age-related mutations and chronic myelomonocytic leukemiaC C Mason, J S Khorashad, S K Tantravahi, et al.
Pageof 4